A meta-analysis showed that in the general IVF population, when patients with polycystic ovary syndrome (PCOS) or poor responders were excluded, GnRH antagonists were associated with lower ongoing pregnancy rate compared to agonists (9). This evidence concerns the gene GNRH1 and polycystic ovary syndrome.